Navigation Links
Angiotech Pharmaceuticals Announces Conference Call and Webcast

Fourth Quarter and Year End 2009 Financial Results

VANCOUVER, Feb. 4 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ( ANPI, TSX: ANP) will host a conference call discussing its financial results for the fourth quarter and year ended December 31, 2009, on Thursday, March 4, 2010 at 9:00 AM ET (6:00 AM PT).

Dial-in information for the earnings call on March 4, 2010 is as follows:

North America (toll-free): 866.770.7129

International: 617.213.8067

Enter Passcode: 69484239

A live webcast of the earnings call will be available to interested parties through Angiotech's website at in the Investors section.

A press release announcing Angiotech's financial results will be issued prior to the call on March 4th at approximately 8:00 AM ET (5:00 AM Pacific).

An archived replay of the call will be available until March 11, 2010.

Replay information is as follows:

North America (toll-free): 888.286.8010

International: 617.801.6888

Enter Passcode: 61713924

About Angiotech Pharmaceuticals

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company. Angiotech discovers, develops and markets innovative treatment s

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
3. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
4. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
5. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
6. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
7. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
8. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
9. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
10. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
11. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
Post Your Comments:
(Date:10/8/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... the development of autologous cell therapies, today announced its schedule ... place in the month of October: Stem ... RepliCel will be presenting at the annual Partnering Forum, ... to be held October 7-9 in La ...
(Date:10/8/2015)... ... October 08, 2015 , ... Cystic fibrosis (CF) is a ... gene and results in dysfunction of the lungs and the gastrointestinal (GI) tract. ... mucus is very difficult to clear, blocks the airways and the glands, and ...
(Date:10/7/2015)... , Oct. 7, 2015  ChromaDex Corp. ... and nutritional ingredients that creates science-based solutions for ... nutrition, and pharmaceutical products, today announced that the ... CEO and Founder, is now available for on-demand ... -->   --> ...
(Date:10/7/2015)... , Oct. 7, 2015   Intrexon Corporation ... today announced it will hold an Investor Day in ... afternoon of Thursday, November 12, 2015. Intrexon,s Chairman and ... other members of the Company,s management team as well ... focus on strategic initiatives, product pipeline, and program updates ...
Breaking Biology Technology:
... VANCOUVER, March 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. ... announced positive clinical study results for its Bio-Seal(TM) ... of Interventional Radiologists Annual Scientific Meeting in San ... efficacy of Bio-Seal in patients undergoing lung biopsy ...
... 9 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY ) ... year and quarter ended December 31, 2008. , Net income ... or $0.37 per basic and $0.36 per diluted share, compared ... basic and diluted share, for the year ended December 31, ...
... SANTA MONICA, Calif., March 9 Cord Blood America, ... stem cell preservation company ( ) focused ... to families nationwide and internationally, said today that it ... eliminating restrictions on Federal funding of stem cell research ...
Cached Biology Technology:
(Date:9/30/2015)... 2015  The U.S. Court of Appeals for the ... in favor of Crossmatch ™, affirming the International ... Suprema and its U.S. partner Mentalix violated Section 337 ... that declares it unlawful to engage in "unfair practices" ... Crossmatch,s patents, the 5,900,993 patent and the 7,203,344 patent. ...
(Date:9/28/2015)... Sept. 28, 2015 CLEAR, the ... its expedited traveler service is coming to ... travel, bringing a frictionless experience, serious speed ... "CLEAR offers our travelers an expedited ... said Jim Smith , Executive Director, ...
(Date:9/28/2015)... JOSE, Calif. , Sept. 28, 2015 ... of human interface solutions, today announced that Lenovo has ... touch fingerprint sensor, FS4202, for its latest smartphone, the ... secure, password-free access to unlock the device and provide ... The feature-rich Natural ID FS4202 sensor ...
Breaking Biology News(10 mins):
... 24, 2011) -- Neither births nor deaths stop the flocking ... J. Toner of the University of Oregon. The notion, he ... new cancer therapies. Picture any scenario in which self-propelled ... fish, and even tiny plastic rods on a vibrating table ...
... saved an iconic Australian lizard species from death at the ... the March issue of The American Naturalist . It,s ... for the arrival of another, says Richard Shine, a biologist ... Cane toads were introduced in Australia in the ...
... injured, the rest of the school takes off in fear, tipped ... in German). Now, researchers reporting online on February 23 in the ... that scary stuff is really made of. Within that ... in fish skin. When a fish is wounded, fragments of the ...
Cached Biology News:
Rabbit polyclonal to Factor IX ( Abpromise for all tested applications). entrezGeneID: 2158 SwissProtID: P00740...
Adhesion Molecule Antibodies...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Polyclonal antiserum raised against conjugated L-isoleucine. Available as antiserum. Amino Acid Antibodies...
Biology Products: